Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 389,523 | 428,413 | 346,639 | 298,276 | 273,957 |
| Cost of Goods | 3,136 | 23,875 | 32,751 | 19,097 | 1,868 |
| Gross Profit | 386,387 | 404,538 | 313,888 | 279,179 | 272,089 |
| Operating Expenses | 243,583 | 285,290 | 465,309 | 294,639 | 324,827 |
| Operating Income | 142,940 | 120,123 | -150,670 | -15,363 | -51,870 |
| Interest Expense | 29,478 | 36,602 | 37,724 | 36,370 | 39,153 |
| Other Income | -4,601 | -24,578 | -5,752 | -3,182 | 9,315 |
| Pre-tax Income | 108,861 | 58,943 | -194,146 | -54,915 | -81,708 |
| Income Tax | 2,685 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 106,176 | 58,943 | -194,146 | -54,915 | -81,708 |
| Net Income Discontinuous | N/A | -37,438 | -88,222 | -62,022 | N/A |
| Net Income | $106,176 | $21,505 | $-282,368 | $-116,937 | $-81,708 |
| EPS Basic Total Ops | 0.67 | 0.14 | -1.85 | -0.78 | -0.56 |
| EPS Basic Continuous Ops | 0.67 | 0.38 | -1.27 | -0.37 | -0.56 |
| EPS Basic Discontinuous Ops | N/A | -0.24 | -0.58 | -0.42 | N/A |
| EPS Diluted Total Ops | 0.66 | 0.14 | -1.85 | -0.78 | -0.56 |
| EPS Diluted Continuous Ops | 0.66 | 0.38 | -1.27 | -0.37 | -0.56 |
| EPS Diluted Discontinuous Ops | N/A | -0.24 | -0.58 | -0.42 | N/A |
| EPS Diluted Before Non-Recurring Items | 0.79 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $146,504 | $125,703 | $-138,700 | $-2,707 | $-40,610 |